Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medline Inc. Class A Common Stock (MDLN) vs Marsh & McLennan Companies, Inc. (MRSH) Price & Performance

Medline Inc. Class A Common StockTrade
Marsh & McLennan Companies, Inc.Trade

Price performance (Past 24H)

Key statistics

Medline Inc. Class A Common Stock vs Marsh & McLennan Companies, Inc. — how do they compare? Medline Inc. Class A Common Stock trades at $35.75 (market cap $31.10B), while Marsh & McLennan Companies, Inc. trades at $176.51 (market cap $82.87B). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 2.7× Medline Inc. Class A Common Stock's market cap, and Marsh & McLennan Companies, Inc. pays a 2.28% dividend while Medline Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medline Inc. Class A Common Stock for 0 Days and Marsh & McLennan Companies, Inc. for 109 Days on average.

MDLNMRSH
Market Cap
$31.10B$82.87B
Volume
4,471,6392,731,994
Sector
HealthFinancials
52-Week High
$49.99$207.02
52-Week Low
$31.64$157.32
Typical Hold Time
0 Days109 Days
Enterprise Value
$41.07B$103.55B
Dividend Yield
—2.28%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Medline Inc. Class A Common Stock

No Aura AI signal available yet.

Marsh & McLennan Companies, Inc.

Marsh (MRSH) trades at $176.67, up 2.86% today, with a bullish technical signal and strong fundamentals including a 14.24% net income margin and consistent earnings beats. The recent acquisition of Accel Holdings, completed October 2, 2026, enhances its global advisory services. Revenue grew to $26.98B in 2025, and cash flow from operations remains robust at $5.29B, supporting a stable financial position.

The stock offers upside to the consensus price target of $202.71, but risks include high debt levels and competitive pressures. Analyst sentiment is mixed with a 'Hold' consensus, while technical indicators show overbought conditions near resistance at $177. Long-term growth depends on integration of acquisitions and margin sustainability.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MDLN
100% Buy0% Sell
Avg holding period · 0 Days
MRSH

No sentiment data available yet.

About Medline Inc. Class A Common Stock

Medline provides medical-surgical products and supply-chain solutions for healthcare providers. Its portfolio and distribution network serve hospitals, clinics, long-term care facilities, and other care settings.

Read more on MDLN →

About Marsh & McLennan Companies, Inc.

Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).

Read more on MRSH →